Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1425 (LINC01425) is a long intergenic non-coding RNA gene that produces a transcript not encoding a protein but potentially playing regulatory roles at the RNA level[1][3][5]. Like other lincRNAs, it is classified as a long non-coding RNA greater than 200 nucleotides, found in regions of the genome not overlapping protein-coding genes[3][5]. LINC01425 and related lincRNAs are implicated in the *fine-tuning of gene expression*, often in a tissue-specific manner, through mechanisms like chromatin remodeling, transcriptional regulation, RNA stabilization, and potentially through enhancer-like activities[3][5]. LINC01425 has been identified in bioinformatic analyses as part of lncRNA signatures that distinguish tumor from normal tissue, especially in lung cancer datasets, supporting a potential role as a cancer biomarker and diagnostic/prognostic tool, though not as a direct therapeutic target or enzyme[2]. No known drugs are reported to target LINC01425 directly, and its molecular mechanism, interacting proteins, and functional effects likely involve regulation of gene expression rather than catalysis or ligand binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1425 (LINC01425).